Manufacturers trying to put into practice these procedures will have to provide robust validation facts to display their equivalence to pharmacopoeial procedures. As these new technologies emerge, the WHO emphasizes the significance of an intensive hazard assessment and validation procedure. According to WHO recommendations, sterility tes